Source: International Congress 2015 – Monitoring and phenotyping COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Vladimír Koblížek (Hradec Kralove, Czech Republic), Vladimir Koblizek, Marek Plutinsky, Jaromir Zatloukal, Patrice Popelkova, Tomas Dvorak, Petr Safranek, Ondrej Sobotik, Alena Vlachova, Petr Vanik, Zuzana Liptakova, Lucie Heribanova, Blanka Snelerova, Pavlina Musilova, Maria Majerciakova, Tomas Vencalek, Eva Kocova, Barbora Novotna, Michal Kopecky, Ondrej Kudela, Katerina Neumannova, Kristian Brat, Eva Volakova, Karel Hejduk, Jan Svancara, Jiri Jarkovsky, Michal Svoboda, Zuzana Zbozinkova. Phenotypical heterogeneity of severe COPD subjects: Baseline results from the Czech multicentre research database of COPD. Eur Respir J 2015; 46: Suppl. 59, 2925

Member's Comments

No comment yet.

Related content which might interest you: Evolution of COPD phenotypes in time - Czech multicentre research database of severe COPD Source: International Congress 2016 – Phenotyping and monitoring airway diseases Year: 2016 Clinical characteristics of patients with frequent COPD exacerbations in a Swiss multicenter COPD cohort study (TOPDOCS) Source: International Congress 2016 – Targeting care, pulmonary rehabilitation, management, and self-management of COPD exacerbations in primary care Year: 2016 GOLD and phenotypes: The new Czech COPD guidelines Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections Year: 2015 COPD therapy based on clinical phenotypes: Baseline data from the Czech multicentre research database of COPD Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD Year: 2015 Are there any differences between Tunisian and European COPD phenotypes? Source: International Congress 2016 – Best abstracts in COPD management Year: 2016 The distribution of phenotypes in a population of severe COPD Source: International Congress 2014 – COPD exacerbations Year: 2014 Gender differences in COPD patients Source: International Congress 2014 – Clinical presentations Year: 2014 COPD: GOLD 2011 and implications for clinical practice Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders Year: 2013 Evaluation of the GOLD 2011 severity criteria across the COPD spectrum Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations Year: 2013 Outcomes in patients with COPD during a 3 year follow-up Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD Year: 2015 Outcomes of COPD exacerbations - a report from the ERS COPD audit in Austria Source: Annual Congress 2013 –COPD: acute exacerbations and others Year: 2013 The relationship between 24-hour symptoms and COPD exacerbations: Results from ASSESS Source: International Congress 2014 – COPD exacerbations Year: 2014 Defining asthma COPD overlap syndrome (ACOS): A population based study Source: International Congress 2016 – COPD and asthma COPD overlap syndrome (ACOS): novelties in terms of prevalence, risk factors, and prognosis in COPD Year: 2016 Effect of allergic sensitization on clinical course of patients with COPD in the Hokkaido COPD cohort study Source: International Congress 2014 – COPD physiopathology Year: 2014 Stable state MR-proadrenomedullin level in COPD patients; a validation study Source: International Congress 2014 – Comorbidities Year: 2014 Severity of airflow obstruction and multicomponent disease staging of COPD in the real-world primary care in Greece: The AEOLUS study Source: International Congress 2016 – Novel avenues in the treatment of COPD I Year: 2016 Three year follow-up of distribution and stability of patients with COPD according GOLD 2014 Source: International Congress 2015 – Clinical assessment in asthma and COPD Year: 2015 Clustering asthma and COPD provides new evidence for both “British” and “Dutch” hypotheses of COPD development Source: Annual Congress 2013 –Risk factors for COPD and lung function decline Year: 2013 Distribution and significance of GOLD 2011 disease severity classification in patients with COPD in China: A national cross-sectional survey Source: Annual Congress 2013 –COPD: acute exacerbations and others Year: 2013 Characterising patterns of prescribing for UK COPD patients with comorbidities or history of pneumonia Source: International Congress 2014 – COPD exacerbations Year: 2014